• OPEN AN ACCOUNT
Indian Indices
Sensex
73,709.69 -143.21
( -0.19%)
Global Indices
Nasdaq
52,511.77 524.74
(1.01%)
Dow Jones
7,731.20 19.47
(0.25%)
Hang Seng
64,728.80 653.38
(1.02%)
Nikkei 225
10,751.68 18.68
(0.17%)
Forex
USD-INR
94.90 0.12
(0.13%)
EUR-INR
106.44 -0.03
(-0.02%)
GBP-INR
126.38 0.12
(0.10%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Indbank Merchant Banking Services Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
511473
INE841B01017
23.1656827
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
INDBANK
15.82
110.95
EPS(TTM)
Face Value()
Div & Yield %
1.58
10
0
 

Lupin receives USFDA approval for Pitolisant Tablets, 4.45 mg and 17.8 mg
Aug 17,2026
Lupin has received the final approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Pitolisant Tablets, 4.45 mg and 17.8 mg.

The U.S. FDA has approved Lupin's Pitolisant Tablets, 4.45 mg and 17.8 mg, as bioequivalent to Wakix® for the indications in the approved labeling.